EN
中文 EN
Company News
Home >Newsroom >Company News
ALL
2026
2025
2024
2023
2022
2021
2020
2019
2018
2016
2015
2014
2013
2012
2007
2026.02.24
Breaking News | CanSino Biologics' Menhycia® (MCV4) Expands Age Indication to Include individuals up to age 6, Enhancing Meningococcal Prevention for School-aged children
2026.02.05
CanSinoBIO Shares Global Practices in Innovative Vaccines at the 2026 World Governments Summit
2026.01.05
CanSinoBIO Advances Pneumococcal Vaccine Portfolio as PCV24 Receives Clinical Trial Approval
1